Results 51 to 60 of about 1,238,132 (184)

Demographical and clinical characteristics of patients with Behcet’s disease and normal individuals.

open access: yes, 2016
Demographical and clinical characteristics of patients with Behcet’s disease and normal individuals.
Kenji Takai (2623126)   +9 more
core   +1 more source

Frequency of clinical manifestations of Behçet's syndrome in patient's referring to Isfahan Al-Zahra Hospital during 1998-2008

open access: yesمجله دانشکده دندانپزشکی اصفهان, 2012
Introduction: Behçet’s disease was initially described by Behçet as a triad of symptoms, including recurring oral ulcers, recurring genital ulcers, and ocular involvement.
Parichehr Ghalyani, Fatemeh Babadi
doaj  

Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis   +54 more
wiley   +1 more source

Diagnosis of different rheumatologic diseases.

open access: yes, 2014
AS: Ankylosing spondylitis; RM: Rheumatoid; BD: Behcet’s disease; WG: Wegner’s granulomatosis; SLE: Systemic lupus erythematosus; ACA: Anticardiolipin antibody syndrome; SS: Sjogren’s syndrome ...
Zuohuizi Yi (580989)   +4 more
core   +1 more source

Measuring success in HS treatment from the physician's and the patient's perspective

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Integrated clinician (HiSCR, IHS4, IHS4‐55, HS‐IGA) and patient (HiSQOL, DLQI) scores, combined with imaging‐based fibrosis and inflammation assessment, redefine treatment success in hidradenitis suppurativa by aligning treat‐to‐target strategies with both inflammatory control and irreversible structural damage.
Georgios Nikolakis   +4 more
wiley   +1 more source

Chronic diarrhea as a presentation of Behçet's disease

open access: yesClinical Case Reports, 2023
Key Clinical Messages Behçet's disease (BD) or syndrome is a chronic, recurrent, multisystem, inflammatory vasculitis disorder with findings of oral aphthous ulcers, genital ulcers, and uveitis.
Marawan Elmassry   +5 more
doaj   +1 more source

Stent-Graft Repair of Common Carotid Pseudoaneurysms in Behcet´s Syndrome [PDF]

open access: yes, 1998
We report on a patient with Behcet’s syndrome who had two pseudoaneurysms at the junction of a saphenous vein graft and the native common carotid artery.
최동훈, 심원흠
core  

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet’s Disease [PDF]

open access: yes, 2015
We describe our experience with a juvenile patient who had refractory intestinal Behcet’s disease that responded to adalimumab, a fully humanized antibody against soluble TNF-α and its receptor.
Satoru Nagata   +5 more
core   +1 more source

Treatment strategies for interstitial granulomatous dermatitis: Systematic review and expert opinion

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Systematic review of 108 studies with a total of 182 patients with interstitial granulomatous dermatitis (IGD). IGD was frequently associated with systemic conditions or drug exposure. Management includes careful medication review and prompt withdrawal of potential triggers. Corticosteroids (systemic and topical) were commonly effective, while biologic
Francesco Bellinato   +4 more
wiley   +1 more source

Genital Ulcer as a Complication of COVID-19 Infection: A Case Report

open access: yes, 2023
Coronavirus disease 2019 (COVID-19), as a pandemic disease and a global concern, is a respiratory tract infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Ali Mohammad Mirjalili   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy